CN113092459A - Gel reagent and kit for fast screening of urease activity and fast screening method - Google Patents

Gel reagent and kit for fast screening of urease activity and fast screening method Download PDF

Info

Publication number
CN113092459A
CN113092459A CN202110384243.XA CN202110384243A CN113092459A CN 113092459 A CN113092459 A CN 113092459A CN 202110384243 A CN202110384243 A CN 202110384243A CN 113092459 A CN113092459 A CN 113092459A
Authority
CN
China
Prior art keywords
gel
urease
reagent
urease activity
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110384243.XA
Other languages
Chinese (zh)
Inventor
许奕鹏
杨晓辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110384243.XA priority Critical patent/CN113092459A/en
Publication of CN113092459A publication Critical patent/CN113092459A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a gel reagent and a kit for rapidly screening urease activity and a rapid screening method, and belongs to the field of medical detection. The gel reagent for fast screening of urease activity comprises 0.2-0.3 volume part of urea; 4-8 parts by volume of phenol red; 0.02-0.1 volume part of proclin 300; 2-10 parts by volume of a pH buffer solution; 5-15 parts by volume of agar gel, wherein the concentration of urea is more than or equal to 7mg/ml, and the concentration of phenol red is more than or equal to 30 multiplied by 10‑3mg/ml. The detection method utilizes the reaction product of urease and urea in saliva or biopsy specimen to initiate corresponding index change to determine the activity of the urease. The detection steps are as follows: and (3) collecting a proper amount of sample by using an applicator device, pushing the whole sample to the lower part of the surface of the gel in the kit from the tweezers by using the applicator device, exposing the sample in the gel as much as possible, standing for 2-3 min, observing the color change of the gel by a visual method, and determining the sample to be urease-positive if the sample turns red and urease-negative if the sample does not turn color.

Description

Gel reagent and kit for fast screening of urease activity and fast screening method
Technical Field
The invention belongs to the field of medical detection, and particularly relates to a gel reagent and a kit for rapidly screening urease activity and a rapid screening method.
Background
This bacterium was first cultured in 1982 by Warren and Marshall, the Robin physician, from a antral biopsy, and was called Campylobacter-like bacterium. Later, this genus was named helicobacter pylori, meaning a spiral or helical bacterium. Helicobacter pylori has been shown to cause active chronic gastritis, a risk factor for gastric cancer and mucosa-associated lymphoid (MALT) lymphoma. Helicobacter pylori inhabits the human digestive tract, usually in the gastric mucosal epithelium, and may also multiply in the oral cavity. Urease produced by the helicobacter pylori can rapidly carry out enzymolysis on urea to produce alkaline ammonia, so that the helicobacter pylori is less susceptible to gastric acid in the stomach.
Urease is a nickel-containing oligomeric enzyme, and can be produced by bacteria such as streptococcus salivarius, actinomyces naeslundii, staphylococcus wowensis, helicobacter pylori and the like which may be contained in oral cavity. Urease can cause a variety of human diseases, including caries, periodontitis, etc., associated with the oral cavity. At present, the detection methods of urease mainly comprise a Nassner reagent colorimetric method, a Raman spectroscopy method, a phenol red indicator method, a colloidal gold immunochromatography method, a precision test paper method and the like. The nano-silver reagent contains mercury, toxic reagents such as silver nitrate and the like are needed for Raman spectroscopy, and the equipment popularization rate is low, so that the two methods are not widely applied. The qualitative detection of urease in saliva can be realized by a saliva test board and a precision test paper method based on the colloidal gold immunochromatography. The urease has high homology, urea can be rapidly hydrolyzed into carbon dioxide and ammonia, and solution pH changes are caused, and based on the principle, the phenol red indicator method can rapidly characterize the urease in living tissues such as gastric mucosa and the like. Therefore, the invention provides a gel reagent for rapid screening by taking phenolphthalein as an indicator, a method for rapid screening of urease activity and a detection kit for rapid chromogenic time of urease activity detection, which have important significance.
Disclosure of Invention
The invention aims to: the urease activity rapid screening method and the urease activity rapid screening kit are improved, have improved detection performance, are convenient and simple to operate and are provided; according to the method, the collected sample can be visually and rapidly tested and detected only by wiping the collected sample in the gel of the detection reagent; the helicobacter pylori is rapidly screened by using the corresponding index change caused by the reaction product of urease and urea in the sample.
In order to achieve the purpose, the invention adopts the following technical scheme:
a gel reagent for rapidly screening urease activity comprises the following components in parts by volume:
Figure BDA0003013856270000021
in the invention, the concentration of urea in the gel reagent is more than or equal to 7mg/ml, preferably 7-20 mg/ml, and further preferably 7 mg/ml; phenol red concentration is greater than or equal to 30 x 10-3mg/ml, preferably 30X 10-3~50×10-3mg/ml, further preferably 30X 10- 3mg/ml。
In the invention, the pH buffer solution comprises at least one acid and at least one alkali which are mixed, and the acid and the alkali are both soluble acid and alkali, and no precipitate is generated during reaction and no chemical reaction is generated with urea. Further, it is preferable that the pH buffer is a mixture of 2- (N-morpholine) ethanesulfonic acid monohydrate and sodium hydroxide.
In the invention, the pH value of the pH buffer solution is adjusted to 5-8, and the activity detection effect of urease is good under the condition.
A kit for rapidly screening urease activity comprises a plastic glass sheet, wherein a concave plastic glass reagent cup is arranged in the center of the glass sheet, a gel reagent for rapidly screening the urease activity is filled in the reagent cup, and the gel reagent is formed by pouring urea, a pH indicator phenol red, a bacteriostatic agent proclin300 and a pH buffer solution into agar gel and uniformly mixing; the upper surface of the plastic glass sheet is also pasted with a label for filling information of a detected person, and the concave plastic glass reagent cup is sealed and covered by the label.
The invention also comprises a method for rapidly screening the activity of urease, which comprises the following specific steps:
a. collecting an appropriate amount of sample with an applicator device;
b. pushing the sample from the applicator device with forceps below the surface of the gel reagent in the kit, exposing the sample as much as possible to the gel reagent and ensuring that the biopsy specimen is completely immersed in the gel reagent;
c. standing for 2-3 min, observing the color change of a gel reagent in the kit by a visual method, and if the color change is red, determining that the kit is urease positive; if the color is not changed, the color is negative to urease.
In the invention, the applicator device is a toothpick, a cotton swab or the like, and the collected sample is any one of saliva, tartar, biopsy stomach and the like.
The bacteriostatic agent proclin300 is used for preventing the growth of pollution urease positive bacteria.
The combined use of the bacteriostatic agent and the buffer can effectively improve the detection performance of urease activity.
The invention has the following advantages and beneficial effects:
according to the invention, the sample is not required to be processed, the sample collected by the applicator device is pushed into the gel, and the reaction product of urease and urea in saliva is used for triggering corresponding index change, so that visual and rapid detection can be realized by a visual method. Compared with the conventional mode, the method has the advantages of no pretreatment process, simple and convenient operation, convenient carrying and transportation, lower cost and higher convenient application performance.
Detailed Description
The present invention is further illustrated by the following examples, but is not limited thereto, and any variations or modifications based on the teachings of the present invention are within the scope of the present invention.
Examples
In the embodiment, 1-25 gel reagents composed of different urea concentrations and different phenol concentrations are provided, the concentrations are measured in mg/ml, the formula of each component is shown in table 1, and the volume is measured in ml.
TABLE 1 examples 1-25 gel reagent compositions
Figure BDA0003013856270000041
Figure BDA0003013856270000051
In this embodiment, a method for rapidly screening urease activity is performed according to the following steps:
a. collecting appropriate amount of sample (saliva, tartar, biopsy stomach, etc.) with toothpick or cotton swab;
b. pushing the sample from the forceps with a toothpick or cotton swab below the surface of the gel reagent in the kit, exposing as much of the sample to the gel reagent as possible and ensuring that the biopsy specimen is fully immersed in the gel reagent;
c. standing for 2-3 min, observing the color change of the gel reagent in the kit by a visual method, wherein if the color change is red, the kit is urease-positive, and if the color change is not red, the kit is urease-negative.
Color development test
According to the above steps, cotton swabs are respectively placed in the oral cavities of several patients with positive helicobacter pylori (i.e. containing urease in the oral cavity) and several normal persons with negative helicobacter pylori (i.e. without urease in the oral cavity) to be wiped to respectively obtain 25 parts of saliva samples, each part of the gel reagent in the examples 1-25 is divided into two parts, the 25 parts of the samples with positive helicobacter pylori are respectively pushed to the lower part of the surface of one part of the gel reagent in the examples 1-25 by using tweezers, the 25 parts of the samples with negative helicobacter pylori are respectively pushed to the lower part of the surface of the other part of the gel reagent in the examples 1-25, and after standing for 2-3 min, the color change of the gel reagent in the examples is observed by a visual method as shown in table 2.
TABLE 2 examination of positive and negative coloration of H.pylori with the gel reagents of examples 1-25
Figure BDA0003013856270000061
Figure BDA0003013856270000071
As can be seen from the data in Table 2, examples 13, 14, 15, 18, 19, 20, 23, 24 and 25 showed red color when they were positive for H.pylori, while the other examples showed no red color when they were positive for H.pylori; all examples did not show a red color when H.pylori was negative. It can be seen that, within the scope of the above examples, the urea concentration is 7mg/ml or more and the phenol red concentration is 30X 10 or more-3The two conditions of mg/ml reach the gel reagent at the same time, and the red color is developed.
(II) color development time test
2ml of urea solution with the concentration of 7, 20, 35, 70 and 140mg/ml and the concentration of 30 multiplied by 10 respectively-36ml of phenolphthalein, 0.06ml of proclin300 solution, 5ml of pH buffer solution (adjusted to 5-8) and 10ml of agar gel are respectively prepared into the 5 gel reagents capable of positively discoloring the helicobacter pylori. And color development time tests were performed for the different dominant quality controls of H.pylori, as shown in Table 3 below. In the table, the strong positive quality control refers to saliva of the same patient in which helicobacter pylori dominance is "positive + + +", and the weak positive quality control refers to saliva of the same patient in which helicobacter pylori dominance is "positive +".
TABLE 3 analysis of the development time for screening helicobacter pylori with different urea concentrations
Figure BDA0003013856270000072
Respectively at a concentration of 30 × 10-3、50×10-3、70×10-3、100×10-36ml of phenolphthalein with the concentration of 7mg/ml, 2ml of urea solution with the concentration of 7mg/ml, 0.06ml of proclin300 solution, 5ml of pH buffer solution (adjusted to 5-8) and 10ml of agar gel, and the 4 gel reagents capable of positively discoloring the helicobacter pylori are respectively prepared. And color development time tests were performed for the different dominant quality controls of H.pylori, as shown in Table 4 below. In the table, the strong positive quality control refers to saliva of the same patient in which helicobacter pylori dominance is "positive + + +", and the weak positive quality control refers to saliva of the same patient in which helicobacter pylori dominance is "positive +".
TABLE 4 analysis of the development time for screening helicobacter pylori with different phenolphthalein concentrations
Figure BDA0003013856270000081
As can be seen from tables 3 and 4, when the concentration of urea is 7mg/ml or more and the concentration of phenolphthalein is 30X 10 or more-3The color development time observed by naked eyes is less than 2min in both strong positive quality control and weak positive quality control at mg/ml(so the observation time is 2-3 min, the gel reagent can be developed), and the development time is reduced along with the increase of the concentration of urea and phenolphthalein, but the reason of the high concentration of urea and phenolphthalein can not be selected, firstly, from the quality control, the color change range of phenolphthalein is pH 8.2-10.0, the phenolphthalein changes to red color when meeting the alkali solution, however, the phenolphthalein rapidly fades to colorless from red in the strong alkali, when the concentration of urea is too high, the urea reacts with urease to generate NH3The phenolic phthalein is easy to dissolve in water, so that the alkalinity of the reagent is increased, and the phenolphthalein is possible to turn red and then returns to be colorless, thereby causing inaccurate observation results; secondly, the proportion of each reagent component is compatible, excessive phenolphthalein is dripped into a dilute acid solution to cause precipitation, so that the solution becomes white and turbid, the pH of the gel reagent in the embodiment of the invention is adjusted to 5-8 by using a pH buffer solution, namely the solution is likely to be weakly acidic, so that the reagent components with too high phenolphthalein concentration are incompatible and the judgment of the discoloration phenomenon is influenced; thirdly, the raw material cost required for high concentration of urea and phenolphthalein is also increased in combination with the consideration of production cost. Therefore, the concentration of the urea is preferably 7-20 mg/ml, and more preferably 7 mg/ml; the concentration of phenolphthalein is preferably 30X 10-3~50×10-3mg/ml, further preferably 30X 10- 3mg/ml。

Claims (10)

1. The gel reagent for rapidly screening the urease activity is characterized by comprising the following components in parts by volume:
Figure FDA0003013856260000011
2. the gel reagent for rapid screening of urease activity according to claim 1, wherein the urea concentration is not less than 7mg/ml, and the phenol red concentration is not less than 30 x 10-3mg/ml。
3. The gel reagent for rapid screening of urease activity according to claim 1, wherein the urea concentration is 7-20 mg/ml, and the phenol red concentration is 30 x 10-3~50×10-3mg/ml。
4. The gel reagent for rapid screening of urease activity according to claim 1, wherein the urea concentration is 7mg/ml, and the phenol red concentration is 30 x 10-3mg/ml。
5. The gel reagent for rapid screening of urease activity according to claim 1, wherein the pH buffer solution comprises at least one acid and at least one alkali which are mixed, the pH is adjusted to 5-8, the acid and the alkali are both soluble acid and alkali, no precipitate is generated during reaction, and no chemical reaction is generated with urea.
6. The gel reagent for rapid screening of urease activity according to claim 1, wherein the pH buffer solution is prepared by mixing 2- (N-morpholine) ethanesulfonic acid monohydrate and sodium hydroxide, and the pH is adjusted to 5-8.
7. A kit for rapidly screening urease activity is characterized by comprising a plastic glass sheet, wherein a concave plastic glass reagent cup is arranged in the center of the glass sheet, a gel reagent for rapidly screening urease activity is filled in the reagent cup, and the gel reagent is formed by pouring urea, a pH indicator phenol red, a bacteriostatic agent proclin300 and a pH buffer solution into agar gel and uniformly mixing; the upper surface of the plastic glass sheet is also pasted with a label used for filling information of a detected person, and the concave plastic glass reagent cup is sealed and covered by the label.
8. A method for rapid screening of urease activity according to any one of claims 1-8, comprising the steps of:
a. collecting an appropriate amount of sample with an applicator device;
b. pushing the sample from the applicator device with forceps below the surface of the gel reagent in the kit, exposing the sample as much as possible to the gel reagent and ensuring that the biopsy specimen is completely immersed in the gel reagent;
c. standing for 2-3 min, observing the color change of a gel reagent in the kit by a visual method, and if the color change is red, determining that the kit is urease positive; if the color is not changed, the color is negative to urease.
9. The method for rapid screening of urease activity according to claim 8, wherein the applicator device is a toothpick, a cotton swab, or the like.
10. The method for rapid screening of urease activity according to claim 8, wherein the collected sample is any one of saliva, tartar, biopsy stomach and the like.
CN202110384243.XA 2021-04-09 2021-04-09 Gel reagent and kit for fast screening of urease activity and fast screening method Pending CN113092459A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110384243.XA CN113092459A (en) 2021-04-09 2021-04-09 Gel reagent and kit for fast screening of urease activity and fast screening method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110384243.XA CN113092459A (en) 2021-04-09 2021-04-09 Gel reagent and kit for fast screening of urease activity and fast screening method

Publications (1)

Publication Number Publication Date
CN113092459A true CN113092459A (en) 2021-07-09

Family

ID=76675906

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110384243.XA Pending CN113092459A (en) 2021-04-09 2021-04-09 Gel reagent and kit for fast screening of urease activity and fast screening method

Country Status (1)

Country Link
CN (1) CN113092459A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114277086A (en) * 2021-12-28 2022-04-05 南京康容健康科技有限公司 Helicobacter pylori rapid detection reagent

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1611938A (en) * 2003-10-27 2005-05-04 上海惠泰医疗科技公司 Pyloric spirillum rapid diagnosis reagent
CN105203529A (en) * 2014-06-13 2015-12-30 亚山制药株式会社 Reagent kit for helicobacter pylori infection diagnosis
CN107257861A (en) * 2015-03-03 2017-10-17 马可·卡诺尼 The supper-fast detection helicobacter pylori in Mucosa Biopsy thing

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1611938A (en) * 2003-10-27 2005-05-04 上海惠泰医疗科技公司 Pyloric spirillum rapid diagnosis reagent
CN105203529A (en) * 2014-06-13 2015-12-30 亚山制药株式会社 Reagent kit for helicobacter pylori infection diagnosis
CN107257861A (en) * 2015-03-03 2017-10-17 马可·卡诺尼 The supper-fast detection helicobacter pylori in Mucosa Biopsy thing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
麦灿荣: "《协和医生答疑丛书 胃病161个怎么办 大字版》", 31 August 2015, 中国盲文出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114277086A (en) * 2021-12-28 2022-04-05 南京康容健康科技有限公司 Helicobacter pylori rapid detection reagent

Similar Documents

Publication Publication Date Title
US4748113A (en) Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
Moore et al. The Formation of Lactic Acid in Dental Plaques: I. Caries-Active Individuals
Yasukawa et al. The relationship between physiologic halitosis and periodontopathic bacteria of the tongue and gingival sulcus
CN111289505A (en) Helicobacter pylori detect reagent box
CN112683893A (en) High-sensitivity helicobacter pylori detection kit
CN113092459A (en) Gel reagent and kit for fast screening of urease activity and fast screening method
CN113281508A (en) Joint detection kit for two pathogenic bacteria of gonococcus and chlamydia trachomatis
KR100247941B1 (en) Composition, kit and method for detecting helicobacter pylori in biopsies
EP0204438B1 (en) Compositions and methods for the detection of urease for the diagnosis of campylobacter pyloridis infection
Starr Studies of human mixed saliva. I. The determination of the hydrogen ion concentration of human mixed saliva
CN111088312A (en) Helicobacter pylori detection kit and preparation method thereof
EP3240907B1 (en) Ultra-rapid detection of helicobacter pylori in gastric mucosal biopsies
CN107064505B (en) A kind of carcinomebryonic antigen detection kit and preparation method thereof based on aptamer autocatalysis
CN115896237A (en) Gel reagent and kit for fast screening of urease activity and fast screening method
JP2008224543A (en) Measuring method of saliva buffer performance
CA1276531C (en) Diagnostic saliva test for detecting periodontal disease
RU2813065C1 (en) Method of diagnostics of oral cavity dysbiosis in patients with metabolic syndrome or type 2 diabetes mellitus
KR100306587B1 (en) Diagnosis method of Helicobacter pylori infection and rapid urease reaction kit for it
US20130273583A1 (en) Testing apparatus for detection of gastrointestinal disorders
RU2244307C2 (en) Method for determination of concentration of serotonin and histamine in biological fluid
JPS60222768A (en) Saliva diagnostic test for detecting illness of alveolar periosteum
RU2566070C1 (en) Method for assessing clinical effectiveness in acute herpetic stomatitis in children
CN116987761A (en) Biological sample treatment fluid, biological sample fungus detection kit and application thereof
JP4074163B2 (en) Medium composition for diagnosis of oral infection
Todd A manual of clinical diagnosis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210709